Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury

Table 1

Demographic, clinical, and neurological features of the patients.

Transplantation group						Control group
Patient	Sex	Age (years)	Time (days)	SCI level	AIS grade	Patient	Sex	Age (years)	Time (days)	SCI level	AIS grade
1	M	34	38	C3	A	1	M	37	168	C6	A
2	M	36	46	C3	A	2	M	56	19	C4	A
3	M	33	81	C7	A	3	M	28	7	C6	A
4	M	45	52	C4	A	4	M	29	58	C6	A
5	M	26	141	C4	A	5	M	34	33	C5	A
6	M	56	75	C4	A	6	F	54	92	C5	A
7	F	45	21	C3	A	7	M	41	35	C3	A
8	M	24	48	C5	A	8	F	35	37	C3	A
9	M	53	123	C3	A	9	F	22	60	C3	A
10	M	32	28	C3	A	10	M	28	92	C6	A
11	M	27	59	C5	A	11	M	35	17	C7	A
12	M	54	213	C3	A	12	M	51	97	C3	A
13	M	57	16	C4	A	13	M	24	66	C4	A
14	M	29	34	C4	A	14	M	39	19	C5	B
15	M	23	18	C4	A	15	M	46	38	C7	B
16	F	23	141	C3	A
17	M	51	24	C4	A
18	F	41	25	C7	B
19	M	18	22	C8	B

Patients are listed according to AIS grade. M = male. F = female. Time between the injury onset and hNSPC transplantation, AIS grade before transplantation, time between the injury onset and the initial evaluation of AIS examination in the hospital, and AIS grade at the initial evaluation.